Cargando…

Acute myocardial infarction and diagnosis-related groups: patient classification and hospital reimbursement in 11 European countries

AIMS: As part of the diagnosis related groups in Europe (EuroDRG) project, researchers from 11 countries (i.e. Austria, England, Estonia, Finland, France, Germany, Ireland, Netherlands, Poland, Spain, and Sweden) compared how their DRG systems deal with patients admitted to hospital for acute myocar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Quentin, Wilm, Rätto, Hanna, Peltola, Mikko, Busse, Reinhard, Häkkinen, Unto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2013
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703310/ https://www.ncbi.nlm.nih.gov/pubmed/23364755 http://dx.doi.org/10.1093/eurheartj/ehs482

Ejemplares similares

Appendectomy and diagnosis-related groups (DRGs): patient classification and hospital reimbursement in 11 European countries
por: Quentin, Wilm, et al.
Publicado: (2011)

From market access to patient access: overview of evidence-based approaches for the reimbursement and pricing of pharmaceuticals in 36 European countries
por: Panteli, Dimitra, et al.
Publicado: (2015)

Coronary artery bypass grafts and diagnosis related groups: patient classification and hospital reimbursement in 10 European countries
por: Gaughan, James, et al.
Publicado: (2014)

The effect of hospital volume on length of stay, re-admissions, and complications of total hip arthroplasty: A population-based register analysis of 72 hospitals and 30,266 replacements
por: Mäkelä, Keijo T, et al.
Publicado: (2011)

Early postoperative mortality similar between cemented and uncemented hip arthroplasty: a register study based on Finnish national data
por: Ekman, Elina, et al.
Publicado: (2019)

Pricing and Reimbursement of Biosimilars in Central and Eastern European Countries
por: Kawalec, Paweł, et al.
Publicado: (2017)

Hospital volume affects outcome after total knee arthroplasty: A nationwide registry analysis of 80 hospitals and 59,696 replacements
por: Pamilo, Konsta J, et al.
Publicado: (2015)

Reimbursement Status and Recommendations Related to Orphan Drugs in European Countries
por: Stawowczyk, Ewa, et al.
Publicado: (2019)

How is intensive care reimbursed? A review of eight European countries
por: Bittner, Martin-Immanuel, et al.
Publicado: (2013)

Reimbursement measures in European countries – findings of a bibliometric literature review
por: Vogler, Sabine, et al.
Publicado: (2015)

Achieving Sustainability and Scale-Up of Mobile Health Noncommunicable Disease Interventions in Sub-Saharan Africa: Views of Policy Makers in Ghana
por: Opoku, Daniel, et al.
Publicado: (2019)

Patient organisations and the reimbursement process for medicines: an exploratory study in eight European countries
por: Noordman, Janneke, et al.
Publicado: (2010)

Reimbursement Legislations and Decision Making for Orphan Drugs in Central and Eastern European Countries
por: Malinowski, Krzysztof Piotr, et al.
Publicado: (2019)

Outcomes-based reimbursement for gene therapies in practice: the experience of recently launched CAR-T cell therapies in major European countries
por: Jørgensen, Jesper, et al.
Publicado: (2020)

An Overview of the Reimbursement Decision-Making Processes in Bulgaria As a Reference Country for the Middle-Income European Countries
por: Kamusheva, Maria, et al.
Publicado: (2018)

For-Profit Hospitals Have Thrived Because of Generous Public Reimbursement Schemes, Not Greater Efficiency: A Multi-Country Case Study
por: Jeurissen, Patrick P. T., et al.
Publicado: (2020)

Reimbursed Medication Adherence Enhancing Interventions in European Countries: Results of the EUREcA Study
por: Ágh, Tamás, et al.
Publicado: (2022)

Dual Agency: A Fresh Perspective to Identify Dilemma Mitigation Strategies – A Response to the Recent Commentaries
por: Waitzberg, Ruth, et al.
Publicado: (2022)

Measuring cost efficiency in the Nordic Hospitals—a cross-sectional comparison of public hospitals in 2002
por: Linna, Miika, et al.
Publicado: (2010)

An international comparative analysis of public reimbursement of orphan drugs in Canadian provinces compared to European countries
por: Ward, Leanne Marie, et al.
Publicado: (2022)

Time to reimbursement of novel anticancer drugs in Europe: a case study of seven European countries
por: Post, H.C., et al.
Publicado: (2023)

Digital Health Reimbursement Strategies of 8 European Countries and Israel: Scoping Review and Policy Mapping
por: van Kessel, Robin, et al.
Publicado: (2023)

Digital Health Applications (DiHA): Approaches to develop a reimbursement process for the statutory health insurance in Austria
por: Goetz, Gregor, et al.
Publicado: (2023)

Comparison of Health Care Costs Between Claimants and Nonclaimants in the No-Fault Compensation System of Finland
por: Järvelin, Jutta, et al.
Publicado: (2019)

Reimbursed medication adherence enhancing interventions in 12 european countries: Current state of the art and future challenges
por: Kardas, Przemysław, et al.
Publicado: (2022)

It probably worked: a Bayesian approach to evaluating the introduction of activity-based hospital payment in Israel
por: Waitzberg, Ruth, et al.
Publicado: (2022)

Dual Agency in Hospitals: What Strategies Do Managers and Physicians Apply to Reconcile Dilemmas Between Clinical and Economic Considerations?
por: Waitzberg, Ruth, et al.
Publicado: (2021)

Reimbursement decisions for medical services in Austria: an analysis of influencing factors for the hospital individual services catalogue between 2008 and 2020
por: Goetz, Gregor, et al.
Publicado: (2022)

Reimbursement for reconstruction by tissue transfer–a European comparison
por: Lotter, Oliver, et al.
Publicado: (2014)

Impact of COVID-19 on health service utilisation in sub-Saharan Africa: protocol for a scoping review
por: Tannor, Elliot Koranteng, et al.
Publicado: (2023)

Assessing the Value of Nusinersen for Spinal Muscular Atrophy: A Comparative Analysis of Reimbursement Submission and Appraisal in European Countries
por: Blonda, Alessandra, et al.
Publicado: (2022)

The impact of country reimbursement programmes on living kidney donations
por: Siddique, Abu Bakkar, et al.
Publicado: (2020)

Policies to Encourage the Use of Biosimilars in European Countries and Their Potential Impact on Pharmaceutical Expenditure
por: Vogler, Sabine, et al.
Publicado: (2021)

Factors predisposing to claims and compensations for patient injuries following total hip and knee arthroplasty
por: Järvelin, Jutta, et al.
Publicado: (2012)

Effects of Activity-Based Hospital Payments in Israel: A Qualitative Evaluation Focusing on the Perspectives of Hospital Managers and Physicians
por: Waitzberg, Ruth, et al.
Publicado: (2020)

Benefit Assessment and Reimbursement of Digital Health Applications: Concepts for Setting Up a New System for Public Coverage
por: Lantzsch, Hendrikje, et al.
Publicado: (2022)

Pathways leading to coronary revascularisation among patients with diabetes in Finland: a longitudinal register-based study
por: Vehko, Tuulikki, et al.
Publicado: (2011)

Sensitive Troponin Assay and the Classification of Myocardial Infarction
por: Shah, Anoop S.V., et al.
Publicado: (2015)

Electrocardiogram Heartbeat Classification for Arrhythmias and Myocardial Infarction
por: Pham, Bach-Tung, et al.
Publicado: (2023)

Comparison of pharmaceutical pricing and reimbursement systems in Turkey and certain EU countries
por: Atikeler, Enver Kagan, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_1spvms6tu8k7pq356m16kjp341